Zurich Cantonal Bank
CPRX

Zurich Cantonal Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Zurich Cantonal Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,643
Closed -$1.14M – 2799
2025
Q4 		$1.14M Buy
+48,643
New +$1.08M ﹤0.01% 1268

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zurich Cantonal Bank's CPRX Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Catalyst Pharmaceutical (CPRX) stake by 1.1% in Q2 2026, selling an estimated $17.7K and leaving 52,373 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Zurich Cantonal Bank first reported a position in CPRX in Q2 2019 and has held it in 28 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Zurich Cantonal Bank held 52,373 shares of Catalyst Pharmaceutical worth $1.65M as of Q2 2026.
  • Zurich Cantonal Bank sold 601 Catalyst Pharmaceutical shares in Q2 2026, an estimated $17.7K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1245 holding.
  • Zurich Cantonal Bank first reported a position in Catalyst Pharmaceutical in Q2 2019 and has held it in 28 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.